Medibio : Update - Proposed issue of securities - MEB

For personal use only

This appendix is available as an online form
Only use this form if the online version is not available	+Rule 3.10.3

Appendix 3B

Proposed issue of +securities

Information and documents given to ASX become ASX's property and may be made public.

If you are an entity incorporated outside Australia and you are proposing to issue a new class of +securities other than CDIs, you will need to obtain and provide an International Securities Identification Number (ISIN) for that class. For offers where the +securities proposed to be issued are in an existing class of security, and the event timetable includes rights (or entitlement for non- renounceable issues), and deferred settlement trading or a representation of such, ASX requires the issuer to advise ASX of the ISIN code for the rights (or entitlement), and deferred settlement trading. This code will be different to the existing class. If the securities do not rank equally with the existing class, the same ISIN code will be used for that security to continue to be quoted while it does not rank.

Further information on the requirement for the notification of an ISIN is available from the Create Online Forms page. ASX is unable to create the new ISIN for non-Australian issuers.

*Denotes minimum information required for first lodgement of this form, with exceptions provided in specific notes for certain questions. The balance of the information, where applicable, must be provided as soon as reasonably practicable by the entity.

+ See chapter 19 for defined terms	Page 1
5 June 2021

For personal use only

	This appendix is available as an online form	Appendix 3B
				Proposed issue of +securities
	Part 1 - Entity and announcement details
	Question	Question	Answer
	no
	1.1	*Name of entity	MEDIBIO LIMITED
		We (the entity here named)
		give ASX the following
		information about a proposed
		issue of +securities and, if ASX
		agrees to +quote any of the
		+securities (including any
		rights) on a +deferred
		settlement basis, we agree to
		the matters set out in
		Appendix 3B of the ASX
		Listing Rules.
		If the +securities are being
		offered under a +disclosure
		document or +PDS and are
		intended to be quoted on ASX,
		we also apply for quotation of
		all of the +securities that may
		be issued under the
		+disclosure document or
		+PDS on the terms set out in
		Appendix 2A of the ASX
		Listing Rules (on the
		understanding that once the
		final number of +securities
		issued under the +disclosure
		document or +PDS is known,
		in accordance with Listing
		Rule 3.10.3C, we will complete
		and lodge with ASX an
		Appendix 2A online form
		notifying ASX of their issue
		and applying for their
		quotation).
	1.2	*Registration type and number	ACN 008 130 336
		Please supply your ABN, ARSN,
		ARBN, ACN or another registration
		type and number (if you supply
		another registration type, please
		specify both the type of registration
		and the registration number).
	1.3	*ASX issuer code	MEB
	1.4	*This announcement is	☐ A new announcement
		Tick whichever is applicable.	☒ An update/amendment to a previous announcement
			☐ A cancellation of a previous announcement
	1.4a	*Reason for update	Extension of the closing date to the Company's Non-
		Answer this question if your response	Renounceable Entitlement Offer ("NREO") by two
		to Q 1.4 is "An update/amendment to	weeks.
		previous announcement". A reason
		must be provided for an update.

+ See chapter 19 for defined terms	Page 2
5 June 2021

		This appendix is available as an online form	Appendix 3B
					Proposed issue of +securities
		1.4b	*Date of previous	20 January 2022
			announcement(s) to this
			update
only			Answer this question if your response
		to Q 1.4 is "An update/amendment to
		previous announcement".
	1.4c	*Reason for cancellation	N/A
		Answer this question if your response
		to Q 1.4 is "A cancellation of previous
		announcement".
	1.4d	*Date of previous	N/A
		announcement(s) to this
		cancellation
use			Answer this question if your response
		to Q 1.4 is "A cancellation of previous
		announcement".
		1.5	*Date of this announcement	16 February 2022
		1.6	*The proposed issue is:	☐ A +bonus issue (complete Parts 2 and 8)
			Note: You can select more than one	☒ A standard +pro rata issue (non-renounceable or
			type of issue (e.g. an offer of		renounceable) (complete Q1.6a and Parts 3 and 8)
			securities under a securities purchase
			plan and a placement, however ASX	☐ An accelerated offer (complete Q1.6b and Parts 3 and 8)
			may restrict certain events from being
personal			announced concurrently). Please	☐ An offer of +securities under a +securities purchase
		contact your ASX listings compliance
		adviser if you are unsure.		plan (complete Parts 4 and 8)
		☐ A non-+pro rata offer of +securities under a
				+disclosure document or +PDS (complete Parts 5 and 8)
			☐ A non-+pro rata offer to wholesale investors under an
				information memorandum (complete Parts 6 and 8)
			☒ A placement or other type of issue (complete Parts 7 and
				8)
	1.6a	*The proposed standard +pro	☒ Non-renounceable
		rata issue is:	☐ Renounceable
		Answer this question if your response
		to Q1.6 is "A standard pro rata issue
		(non-renounceable or renounceable)."
		Select one item from the list
		An issuer whose securities are
		currently suspended from trading
		cannot proceed with an entitlement
		offer that allows rights trading. If your
		securities are currently suspended,
For			please consult your ASX listings
		compliance adviser before proceeding
		further.
	1.6b	*The proposed accelerated	☐ Accelerated non-renounceable entitlement offer
		offer is:		(commonly known as a JUMBO or ANREO)
		Answer this question if your response	☐ Accelerated renounceable entitlement offer
		to Q1.6 is "An accelerated offer"
		Select one item from the list		(commonly known as an AREO)
		☐ Simultaneous accelerated renounceable entitlement
		An issuer whose securities are
			currently suspended from trading		offer (commonly known as a SAREO)
			cannot proceed with an entitlement	☐ Accelerated renounceable entitlement offer with dual
			offer that allows rights trading. If your
			securities are currently suspended,		book-build structure (commonly known as a
			please consult your ASX listings		RAPIDS)
			compliance adviser before proceeding	☐ Accelerated renounceable entitlement offer with retail
			further.
					rights trading (commonly known as a PAITREO)

+ See chapter 19 for defined terms	Page 3
5 June 2021

For personal use only

This appendix is available as an online form	Appendix 3B
	Proposed issue of +securities

Part 3 - Details of proposed entitlement offer

If your response to Q1.6 is "A standard pro rata issue (non-renounceable or renounceable)" or "An accelerated offer", please complete parts 3A, 3F and 3G and the details of the securities proposed to be issued in Part 8. Please also complete Parts 3B and 3C if your response to Q1.6 is "A standard pro rata issue (non-renounceable or renounceable)" and Parts 3D and 3E if your response to Q1.6 is "An accelerated offer". Refer to sections 2,3,4,5 and 6 of Appendix 7A of the Listing Rules for the respective timetables for entitlement offers, including non-renounceable, renounceable and accelerated offers.

Part 3A - Proposed entitlement offer - conditions

Question	Question	Answer
No.
3A.1	*Do any external approvals need to be	No
	obtained or other conditions satisfied before
	the entitlement offer can proceed on an
	unconditional basis?
	For example, this could include:
	•	+Security holder approval
	•	Court approval
	• Lodgement of court order with +ASIC
	•	ACCC approval
	•	FIRB approval
	Disregard any approvals that have already been
	obtained or conditions that have already been satisfied.
	If any of the above approvals apply to the entitlement
	offer, they must be obtained before business day 0 of
	the timetable. The relevant approvals must be received
	before ASX can establish an ex market in the
	securities.
3A.1a	Conditions

Answer these questions if your response to Q3A.1 is "Yes".

*Approval/ condition	*Date for	*Is the date	**Approval received/	Comments
Type	determination	estimated or	condition met?
Select the applicable	The 'date for	actual?	Please respond "Yes" or
approval/condition	determination' is the		"No". Only answer this
from the list (ignore	date that you expect to		question when you know
those that are not	know if the approval is		the outcome of the
applicable). More than	given or condition is		approval. Note that you
one approval/condition	satisfied (for example,		will need to lodge an
can be selected.	the date of the security		updated Appendix 3B
	holder meeting in the		showing that all required
	case of security holder		approvals have been
	approval or the date of		obtained and conditions
	the court hearing in the		have been met prior to
	case of court approval).		business day 0 in the
			timetable for the
			entitlement offer in
			Appendix 7A of the
			listing rules.
+Security holder
approval
Court approval
Lodgement of court
order with +ASIC
ACCC approval
FIRB approval
Other (please specify
in comment section)

+ See chapter 19 for defined terms	Page 4
5 June 2021

This appendix is available as an online form	Appendix 3B
	Proposed issue of +securities

Part 3B - Proposed standard pro rata issue entitlement offer - offer details

If your response to Q1.6 is "A standard pro rata issue (non-renounceable or renounceable)", please complete the relevant questions in this part.

only
Question	Question	Answer
	No.
	3B.1	*Class or classes of +securities that will	MEB : ORDINARY FULLY PAID
		participate in the proposed entitlement offer
		(please enter both the ASX security code &
		description)
		If more than one class of security will participate in the
		proposed entitlement offer, make sure you clearly
use		identify any different treatment between the classes.
3B.2	*Class of +securities that will be issued in	1.	MEB
	the proposed entitlement offer (please enter	1.	MEBOC
		both the ASX security code & description)
	3B.3	*Offer ratio	1.	1 for 3
		Enter the quantity of additional securities to be offered	2. Each shareholder that successfully
		for a given quantity of securities held (for example, 1		subscribes to shares under the
		for 2 means 1 new security will be offered for every 2		NREO will receive a free attaching
		existing securities held).
personal		Please only enter whole numbers (for example, an		option on the basis of 1 for 2.
	entitlement offer of 1 new security for every 2.5	2.	343,509,055
	to be issued (subject to rounding)
		existing securities held should be expressed as "2 for
		5").
		Listing rule 7.11.3 requires that non-renounceable
		offers must not exceed a ratio of 1:1. Please ensure
		that you comply with listing rule 7.11.3 or have a
		waiver from that rule.
	3B.4	*What will be done with fractional	☒ Fractions rounded up to the next whole
		entitlements?	number
		Select one item from the list.	☐ Fractions rounded down to the nearest
			whole number or fractions disregarded
			☐ Fractions sold and proceeds distributed
			☐ Fractions of 0.5 or more rounded up
			☐ Fractions over 0.5 rounded up
			☐ Not applicable
	3B.5	*Maximum number of +securities proposed	1.	687,018,109
For
3B.6	*Will individual +security holders be	Yes
		permitted to apply for more than their
		entitlement (i.e. to over-subscribe)?
	3B.6a	*Describe the limits on over-subscription	Eligible shareholders who apply for their
		Answer this question if your response to Q3B.6 is	Entitlement in full may apply for additional
		"Yes".	Shares under the Shortfall. If eligible
			shareholders subscribe for more Shares than
			are available under the Shortfall, the
			Company will apply a scale-back procedure
			to ensure a fair allocation of the shortfall.
	3B.7	*Will a scale back be applied if the offer is	Yes
		over-subscribed?

+ See chapter 19 for defined terms	Page 5
5 June 2021